Dow Down 1.40% Nasdaq Down 1.59%

Cyclacel Pharmaceuticals, Inc. (CYCC)

-NasdaqGM
2.94 Down 0.10(3.29%) 3:59PM EDT
Prev Close:3.04
Open:3.01
Bid:2.80 x 500
Ask:3.90 x 1000
1y Target Est:9.50
Beta:2.22
Next Earnings Date:N/A
Day's Range:2.90 - 3.02
52wk Range:2.88 - 5.25
Volume:105,181
Avg Vol (3m):89,813
Market Cap:66.67M
P/E (ttm):N/A
EPS (ttm):-0.97
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CYCC

Comparison

Symbol% ChgMkt Cap
CYCCDown 3.29%66.67M
AZNDown 1.27%89.08B
JNJDown 2.15%294.16B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):50.69
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.01
Quarterly EPS Est (Sep-14) :-0.27
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cyclacel Pharmaceuticals, Inc., a development-stage biopharmaceutical company, develops and commercializes mechanism-targeted drugs to treat human cancers and other serious diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback